Lawrence Schimmel - Apr 2, 2022 Form 4 Insider Report for Nutex Health, Inc. (NUTX)

Role: Chief Medical Information Off
Signature: /s/ Lawrence Schimmel
Stock symbol: NUTX
Transactions as of: Apr 2, 2022
Transactions value $: -$3,037,489,436
Form type: 4
Date filed: 8/2/2022, 02:26 PM
Previous filing: Apr 8, 2022
Next filing: Aug 4, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NUTX	Common Stock	Conversion of derivative security	$30.4K	+19.6K	+8.37%	$1.55	254K	Apr 2, 2022	Direct
transaction	NUTX	Common Stock	Exercise of in-the-money or at-the-money derivative security	$15.2K	+9.8K	+3.86%	$1.55	263K	Apr 2, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUTX	Convertible Promissory Note	Conversion of derivative security	-$3.04B	-30.4K	-100%	$100,000.00^*	0	Apr 2, 2022	Common Stock	19.6K	$1.55	Direct	F1
transaction	NUTX	Warrant	Exercise of in-the-money or at-the-money derivative security	$0	-9.8K	-100%	$0.00^*	0	Apr 2, 2022	Common Stock	9.8K	$1.55	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021.
F2	Warrant No. 2019A-14 issued on 12/31/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021.